FDA’s Gottleib Resigns

Share this story on:

Share on facebook
Share on twitter
Share on linkedin

“Scott Gottlieb, MD, announced his resignation as chief of the FDA on March 5. He plans to leave his post sometime next month.

“Dr. Gottlieb has served in his post since May 2017, and has been a staunch advocate for developing new drugs and regulation. His resignation may especially affect biotech and pharmaceutical companies, as well as tech companies looking to move into the healthcare space.

“Before appointing Dr. Gottlieb, President Donald Trump considered a variety of candidates for the position, including individuals who sought to dismantle FDA drug oversight and review process — a move that worried many pharma executives and health sector investors, STAT News reports.

“‘I think Scott was pretty much a best-case scenario for the sector that one could see under a Trump administration, so any replacement is probably going to be worse. Hopefully not much, much worse,’ a Baird biotech analyst told STAT.

“During his time at the FDA, the physician and former venture capitalist also gained a reputation as a supporter of healthcare innovation, establishing programs like Pre-Cert, software that allowed tech giants like Apple to get approval for low-risk health products faster, CNBC reports.

“‘Scott did a lot culturally to make the agency easier to work with,’ Bob Kocher, a partner at venture capital firm Venrock, told CNBC. ‘I think he’ll be missed by many in the tech industry, including the startups.'”  Source: “Becker’s Hospital Review”

Teresa
Teresa

Recent Posts

Teresa

Unprecedented Collaboration

“… COVID 19 has led to unprecedented worldwide collaboration among scientists, medical doctors, health and government officials, and manufacturers…The arrival of this vaccine in Michigan

Read More »
Teresa

Questions about Vaccines?

“People with questions about vaccines – including the COVID 19 vaccination should consult a creditable source with answers based on medical science.  Sources for vaccination

Read More »
Teresa

As of December 20, 2020:

According to the Centers for Disease Control (CDC), as of 1 pm on December 20th: 2,838,225 doses of the new PfizerBioNTech COVID 19 vaccine have

Read More »
Teresa

Moderna COVID-19 Vaccine

“This vaccine is authorized for emergency use in individuals aged 18 years and older.  This is a two-dose vaccine, given one month apart.  Clinical trial

Read More »

copyright 2020 Evansville Insurance Center